Sofinnova Partners
Overview
Sofinnova Partners is a healthcare investment firm founded in 1976 that focuses on life science investing, primarily therapeutic drugs, and supports companies from inception through IPO.
Classification
- Headquarters
- Paris, France
- Geographic focus
- Europe
- Stage
- any
- Portfolio
- 5 companies
Fund details
- Fund size
- €1.2bn
- AUM
- $4.6B
- Founded
- 1976
Signals graph-derived
Thesis & focus
collaborative partner through drug development, regulatory process, company building, and IPO
Spark Therapeutics (acquired by Roche 2019)
therapeutic drugs, life science
Innovation for Life
Investment thesis
Sofinnova operates at the intersection of life science, finance, and innovation, focusing on transforming biotechs from inception to reality. They provide a collaborative, experienced partnership to guide companies through drug development, regulatory processes, and eventual IPO.
Portfolio companies
No portfolio companies linked yet.
Co-investors
Loading co-investment network…
No co-invest data available.
Source: vc_export
Website preview visit ↗
